(Q42644400)

English

Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 November 2017

Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial (English)

1 reference

Europe PubMed Central

4 November 2017

phase II clinical trial

0 references

chemoradiotherapy

0 references

phase III clinical trial

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

8

1 reference

Europe PubMed Central

4 November 2017

Jean-Yves Douillard

6

object named as

Jean-Yves Douillard

1 reference

Europe PubMed Central

4 November 2017

Carmen Llacer Moscardo

11

object named as

Carmen Llacer-Moscardo

1 reference

Europe PubMed Central

4 November 2017

5

object named as

Sophie Gourgou-Bourgade

1 reference

Europe PubMed Central

4 November 2017

author name string

Thierry Conroy

1

1 reference

Europe PubMed Central

4 November 2017

Marie-Pierre Galais

2

1 reference

Europe PubMed Central

4 November 2017

Jean-Luc Raoul

3

1 reference

Europe PubMed Central

4 November 2017

Olivier Bouché

4

1 reference

Europe PubMed Central

4 November 2017

Pierre-Luc Etienne

7

1 reference

Europe PubMed Central

4 November 2017

Isabelle Martel-Lafay

9

1 reference

Europe PubMed Central

4 November 2017

Pierre Michel

10

1 reference

Europe PubMed Central

4 November 2017

Eric François

12

1 reference

Europe PubMed Central

4 November 2017

Gilles Créhange

13

1 reference

Europe PubMed Central

4 November 2017

Meher Ben Abdelghani

14

1 reference

Europe PubMed Central

4 November 2017

Beata Juzyna

15

1 reference

Europe PubMed Central

4 November 2017

Laurent Bedenne

16

1 reference

Europe PubMed Central

4 November 2017

Antoine Adenis

17

1 reference

Europe PubMed Central

4 November 2017

Fédération Francophone de Cancérologie Digestive and UNICANCER-GI Group

18

1 reference

Europe PubMed Central

4 November 2017

publication date

18 February 2014

1 reference

Europe PubMed Central

4 November 2017

Lancet Oncology Commission

1 reference

Europe PubMed Central

4 November 2017

15

1 reference

Europe PubMed Central

4 November 2017

3

1 reference

Europe PubMed Central

4 November 2017

305-314

1 reference

Europe PubMed Central

4 November 2017

Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970028-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970028-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970028-2

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose folinic acid with 5-fluorouracil bolus and continuous infusion in the treatment of advanced gastric and oesophageal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970028-2

7 January 2021

based on heuristic

inferred from DOI database lookup

5-Fluorouracil, folinic acid, etoposide and cisplatin chemotherapy for locally advanced or metastatic carcinoma of the oesophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970028-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Combining radiation with oxaliplatin: a review of experimental results

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970028-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Oxaliplatin in combination with protracted-infusion fluorouracil and radiation: report of a clinical trial for patients with esophageal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970028-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Concurrent oxaliplatin, 5-fluorouracil, and radiotherapy in the treatment of locally advanced esophageal carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970028-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Multi-center phase II trial of chemo-radiotherapy with 5-fluorouracil, leucovorin and oxaliplatin in locally advanced esophageal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970028-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of oxaliplatin, leucovorin and fluorouracil in patients with advanced carcinoma of the esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970028-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I trial of oxaliplatin with fluorouracil, folinic acid and concurrent radiotherapy for oesophageal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970028-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II randomised trial of chemoradiotherapy with FOLFOX4 or cisplatin plus fluorouracil in oesophageal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970028-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Recursive partitioning analysis of pretreatment variables of 416 patients with locoregional esophageal cancer treated with definitive concomitant chemoradiotherapy on Intergroup and Radiation Therapy Oncology Group trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970028-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Patterns of treatment failure and prognostic factors associated with the treatment of esophageal carcinoma with chemotherapy and radiotherapy either as sole treatment or followed by surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970028-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970028-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970028-2

7 January 2021

based on heuristic

inferred from DOI database lookup

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970028-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical impact of criteria for complete response (CR) of primary site to treatment of esophageal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970028-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A Multiple Testing Procedure for Clinical Trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970028-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970028-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970028-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970028-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970028-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Thromboembolism in patients with advanced gastroesophageal cancer treated with anthracycline, platinum, and fluoropyrimidine combination chemotherapy: a report from the UK National Cancer Research Institute Upper Gastrointestinal Clinical Studies Gr

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970028-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of venous thromboembolism in patients with cancer treated with Cisplatin: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970028-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II randomized trial of two nonoperative regimens of induction chemotherapy followed by chemoradiation in patients with localized carcinoma of the esophagus: RTOG 0113

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970028-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970028-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II study of paclitaxel, carboplatin, and radiation with or without surgery for esophageal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970028-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Cisplatin/Irinotecan versus carboplatin/paclitaxel as definitive chemoradiotherapy for locoregionally advanced esophageal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970028-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemoradiation for esophageal cancer: institutional experience with three different regimens.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970028-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1470-2045(14)70028-2

1 reference

Europe PubMed Central

4 November 2017

1 reference

Europe PubMed Central

4 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42644400&oldid=2034262747"